5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Sanofi India Ltd.

•
sanofiindialtd.comBSE: 500674NSE: SANOFI
Market Cap₹ 7,093 Cr.
Current Price
High / Low₹ 5,114 / 3,054
Stock P/E21.9
Book Value₹ 359
Price to Book13.89
Dividend Yield3.99 %
ROCE55.5 %
ROE44.5 %
Face Value₹ 10

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company is almost debt free
  • Company has a healthy return on capital (ROCE) of 49.3%
  • Company has a good return on equity (ROE) track record: 3 Years ROE 38.1%
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.13x)
  • Stock looks reasonably valued - P/E of 21.9 is below its historical median
  • Company generates healthy free cash flow

CONS

  • Stock is trading at 13.9x its book value
  • Recurring exceptional / one-off items are inflating headline profit

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY 50NIFTY 500NIFTY LARGEMIDCAP 250NIFTY 100NIFTY 200
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.2410320.301152.1691503.501062.9612.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.SANOFI3079.8517.167093.093.9991.30-93.37514.909.7455.4626.08
Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
515491469511464524515536406475420472438
393377370374348404397364311341330330332
Operating Profit1221141001371161201181729513490143106
OPM %23.62%23.13%21.23%26.84%24.96%22.84%22.98%32.08%23.36%28.23%21.51%30.24%24.24%
16119-23-1421439-22346
Interest1000000000100
Depreciation9999991010991099
Profit before Tax12711599104921131221659410283138112
Tax %36.37%29.67%29.81%31.10%25.95%27.00%25.29%27.71%26.14%25.71%25.66%25.60%25.65%
Net Profit8181707268829112070766210384
53.3766.0830.2631.2629.6235.6939.6451.8930.1832.9926.7944.5536.26

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Dec 2024Dec 2025TTM
1,9962,0131,8371,805
1,5091,5231,3461,332
Operating Profit487490491473
OPM %24.40%24.35%26.74%26.22%
80-21-8-9
Interest2222
Depreciation36373736
Profit before Tax528431445436
Tax %31.01%27.28%26.53%25.65%
Net Profit365314327324
EPS158.52136.39142.04—
Dividend Payout %105.35%85.78%86.59%—

COMPOUNDED SALES GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

COMPOUNDED PROFIT GROWTH

10 Years:
—
5 Years:
—
3 Years:
—

STOCK PRICE CAGR

10 Years:
-3%
5 Years:
-18%
3 Years:
-24%
1 Year:
-39%

RETURN ON EQUITY

10 Years:
—
5 Years:
—
3 Years:
38%
Last Year:
44%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Corporate actions

2026

Apr 22

₹ 4.80

Rs.48.0000 per share(480%)Final Dividend

2025

Nov 7

₹ 7.50

Rs.75.0000 per share(750%)Interim Dividend

2025

Apr 25

₹ 11.70

Rs.117.0000 per share(1170%)Final Dividend

2024

May 3

₹ 11.70

2024

Mar 7

₹ 5

2023

Apr 28

₹ 18.30

Rs.183.0000 per share(1830%)Special Dividend

2023

Apr 28

₹ 19.40

2022

Aug 5

₹ 19.30

Special Interim Dividend

2022

Apr 12

₹ 30.90

Rs.309.0000 per share(3090%)Special Dividend

2022

Apr 12

₹ 18.10

Rs.309.0000 per share(3090%)Special Dividend

2021

Apr 19

₹ 24

Rs.240.0000 per share(2400%)Special Dividend

2021

Apr 19

₹ 12.50

Rs.240.0000 per share(2400%)Special Dividend

2018

Aug 6

₹ 1.80

Rs.18.0000 per share(180%)Interim Dividend

2018

Apr 26

₹ 5.30

Rs.53.0000 per share(530%)Final Dividend

2017

Jul 31

₹ 1.80

Rs.18.0000 per share(180%)Interim Dividend

2017

Apr 25

₹ 5

Rs.50.0000 per share(500%)Final Dividend

2016

Aug 4

₹ 1.80

Rs.18.0000 per share(180%)Interim Dividend

2016

Apr 13

₹ 2.20

Rs.14.0000 per share Special One Time Dividend + Rs.8.000 per share Specal One time Diamond Jubilee Dividend = Rs.22.0000 per share (220% ) Special Dividend

2016

Apr 13

₹ 2.50

Dec 2023Dec 2024Dec 2025
Equity Capital232323
924768654
141414
Trade Payables292406194
3,4513,4683,538
Total Liabilities4,7034,6794,423
315312304
Capital Work in Progress131812
200
664500312
132230177
Cash & Bank405295275
3,1733,3243,344
Total Assets4,7034,6794,423

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Dec 2024Dec 2025
231462438
Cash from Investing36-19-11
Cash from Financing-878-392-448
-61250-21

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Dec 2023Dec 2024Dec 2025

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
60.4060.4060.4060.4060.4060.4060.4060.4060.40
5.815.785.645.585.615.575.555.655.69
22.6022.6222.7123.0223.0622.2821.3021.1219.87
Government0.000.000.000.000.000.000.000.000.00
11.2011.2011.2611.0110.9411.7512.7412.8314.05

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-08
Action(s) taken or orders passed

2026-09-08 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI (LODR) Regulations )

2026-08-31
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company

2026-08-31 - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Receipt of Show Cause Notice from GST Authorities

2026-08-13
General Updates

2026-08-13 - Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-11
General Updates

2026-08-11 - Please find enclosed intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

2026-08-10
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-10 - Sanofi India Limited has informed the Exchange about Transcript of Investor / Analysts Call.

2026-08-06
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-06 - Sanofi India Limited has informed the Exchange about Link of Video Recording of Investor / Analysts Call

2026-08-05
Copy of Newspaper Publication

2026-08-05 - Sanofi India Limited has informed the Exchange about copies of Newspaper Publication of Financial Results for the quarter and half year ended 30th June 2026

2026-08-05
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-05 - Sanofi India Limited has informed the Exchange about Investor / Analysts Call - Presentation

2026-08-04
General Updates

2026-08-04 - Sanofi India Limited has informed the Exchange about Intimation Under Regulation 30(5) Of the Listing Regulations

News

Recent coverage and analyst commentary for SANOFI

Loading news…

🤖

AI Stock Analyst

Sanofi India Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login